References
- Krishnan A, Hamilton JP, Alqahtani SA, Woreta TA. A narrative review of coronavirus disease 2019 (COVID-19): Clinical, epidemiological characteristics, and systemic manifestations. Intern Emerg Med. 2021; 16:815–30.
- El-Anwar MW, Elzayat S, Fouad YA. ENT manifestation in COVID-19 patients. Auris Nasus Larynx. 2020; 47:559–64.
- Naunheim MR, Zhou AS, Puka E, Franco RA Jr, Carroll TL, Teng SE, et al. Laryngeal complications of COVID-19. Laryngoscope Investig Otolaryngol. 2020; 5:1117–24.
- Tahir E, Kavaz E, Çengel Kurnaz S, Temoçin F, Atilla A. Patient reported voice handicap and auditory-perceptual voice assessment outcomes in patients with COVID-19. Logoped Phoniatr Vocol. 2023; 48:88–97.
- Lechien JR, Chiesa-Estomba CM, Cabaraux P, Mat Q, Huet K, Harmegnies B, et al. Features of mild-to-moderate COVID-19 patients with dysphonia. J Voice. 2022; 36:249–55.
- Cantarella G, Aldè M, Consonni D, Zuccotti G, Berardino FD, Barozzi S, et al. Prevalence of dysphonia in non hospitalized patients with COVID-19 in Lombardy, the Italian epicenter of the pandemic. J Voice. 2023; 37:605–9.
- Al-Ani RM, Rashid RA. Prevalence of dysphonia due to COVID-19 at Salahaddin General Hospital, Tikrit City, Iraq. Am J Otolaryngol. 2021; 42:103157. doi: 10.1016/j.amjoto.2021.103157
- Rosen CA, Lee AS, Osborne J, Zullo T, Murry T. Development and validation of the voice handicap index-10. Laryngoscope. 2004; 114:1549–56.
- Jaruchinda P, Suwanwarangkool T. Cross-cultural adaptation and validation of the voice handicap index into Thai. J Med Assoc Thai. 2015; 98:1199–208.
- Jusri S, Jaruchinda P. The validity of the Thai Voice Handicap Index–10. In press.
- Suphanchaimat R, Teekasap P, Nittayasoot N, Phaiyarom M, Cetthakrikul N. Forecasted trends of the new COVID-19 epidemic due to the Omicron variant in Thailand, 2022. Vaccines (Basel). 2022; 10:1024. doi: 10.3390/vaccines10071024
- Cohen S, Kim J, Roy N, Asche C, Courey M. Prevalence and causes of dysphonia in a large treatment-seeking population. Laryngoscope. 2012; 122:343–8.
- Verma H, Shah J, Akhilesh K, Shukla B. Patients' perspective about speech, swallowing and hearing status post-SARS-CoV-2 (COVID-19) recovery: E-survey. Eur Arch Otorhinolaryngol. 2022; 279:2523–32.
- Byeon H. Prevalence of perceived dysphonia and its correlation with the prevalence of clinically diagnosed laryngeal disorders: The Korea National Health and Nutrition Examination Surveys 2010–2012. Ann Otol Rhinol Laryngol. 2015; 124:770–6.
- Haddad G, El Hage A, Yammine Y, Hamdan AL. Prevalence of obesity in patients with dysphonia. J Voice. 2024; 38:741–5.
- Lechien JR, Barillari MR, De Marrez LG, Hans S. Dysphonia in COVID-19 patients: Direct or indirect symptom? Am J Otolaryngol. 2022; 43:103246. doi: 10.1016/j.amjoto.2021.103246
- Vance D, Shah P, Sataloff RT. COVID-19: Impact on the musician and returning to singing; a literature review. J Voice. 2023; 37:292.e1–292.e8.
- Accorsi EK, Britton A, Fleming-Dutra KE, Smith ZR, Shang N, Derado G, et al. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants. JAMA. 2022; 327:639–51.
- Magen O, Waxman JG, Makov-Assif M, Vered R, Dicker D, Hernán MA, et al. Fourth dose of BNT162b2 mRNA COVID-19 vaccine in a nationwide setting. N Eng J Med. 2022; 386:1603–14.
- Regev-Yochay G, Gonen T, Gilboa M, Mandelboim M, Indenbaum V, Amit S, et al. Efficacy of a fourth dose of COVID-19 mRNA vaccine against Omicron. N Eng J Med. 2022; 386:1377–80.
- Westerhof I, de Hoog M, Ieven M, Lammens C, van Beek J, Rozhnova G, et al. The impact of variant and vaccination on SARS-CoV-2 symptomatology; three prospective household cohorts. Int J Infec Dis. 2023; 128:140–7.